Characteristic | No (%) or mean ± SEM |
---|---|
Age, year | 45.71 ± 1.50 |
Male | 33 (46.5%) |
AML | 35 (49.3%) |
ALL | 22 (31.0%) |
Lymphoma | 8 (11.3%) |
Multiple myeloma | 4 (5.6%) |
Relapsed malignancy | 17 (23.9%) |
History of HSCT | 13 (18.3%) |
Neutropenia duration, days | 22.54 ± 1.65 |
ARDS during neutropenia recovery | 38 (53.5%) |
Pneumonia during neutropenia | 45 (63.4%) |
Mechanical ventilation | 53 (74.6%) |
Renal replacement therapy | 21 (29.6%) |
In-ICU mortality | 50 (70.4%) |